TFTakashi Fujisawa

Takashi Fujisawa

*This is an algorithmically generated author record based on publicly available information.

Takashi Fujisawa has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 1 July 2013
      • Vol. 110  (7) , 1258-64

    [A case of liver and bone metastases after complete resection of gastric GIST effectively treated with radiotherapy and imatinib mesylate].

    by Takashi Fujisawa, Yuko Matsumoto, Akihiko Nishizawa, Masafumi Takata

    A 70's man was admitted to our hospital because of lumbago and paresthesia in the right lower extremity. He underwent surgical resection of gastric gastrointestinal stromal tumor (GIST), which was classified to the high-risk group according to the modified-Fletcher's classification, one and half years ago. CT, MRI, and PET-CT showed metastases to a part of the liver (S3-4), the 12th thoracic vertebra, and the sacral bone. Subsequently, radiotherapy for the bone metastasis and administration of imatinib mesylate were started. Four months after the initial admission, the liver and the bone metastatic lesions achieved PET-complete response (CR). This report shows that multimodality therapy with radiotherapy and imatinib mesylate was effective for liver and bone metastases after complete resection of gastric GIST.


  • Intra-abdominal plexiform neurofibromatosis including periportal, mesentery, and gastrointestinal tract involvement in neurofibromatosis type 1: case report and review of the literature

    by Takashi Fujisawa, Masafumi Takata, Sachiko Ouchi, Shigemitsu Ueyama, Takahiro Nakajima, Masaaki Mitsutsuji, Takashi Kawamura, Masanori Toyoda, Akiji Okamura

    We report a case of intra-abdominal plexiform neurofibromatosis, including periportal, mesenteric, and gastrointestinal tract involvement, in a patient with von Recklinghausen’s disease/neurofibromatosis type 1 (NF-1). A 26-year-old man with familial NF-1 was admitted to hospital for further examination of an abnormal hepatic mass along the portal vein. Esophagogastroduodenoscopy revealed antral wall thickening and swelling of the papilla of Vater. Mucosal biopsies taken from the duodenum revealed possible ganglioneuromatosis. Abdominal ultrasonography, contrast-enhanced computed tomography, and magnetic resonance imaging revealed an abnormal periportal mass with serpiginous extension into the liver along the portal vein and the mesentery, which is the typical spread pattern of plexiform neurofibromatosis. A laparotomy and cholecystectomy for gallstones were performed, and this patient was diagnosed as having intra-abdominal plexiform neurofibromatosis. This is the 15th case of intrahepatic periportal plexiform neurofibromatosis and the 16th case of diffuse ganglioneuromatosis associated with NF-1 in the English literature. The imaging findings of the lesion have been followed for 10 years; there has been slight growth of the mass, but no malignant transformation has been found. The previously reported cases are reviewed.


    • 1 December 2007
      • Vol. 34  (13) , 2297-300

    [Complete histological response in gastric cancer stage IV after neoadjuvant chemotherapy including S-1 combined with CDDP--report of a case].

    by Takashi Fujisawa, Wataru Sano, Sachiko Ouchi, Shigemitsu Ueyama, Toshiyuki Mori, Daisuke Tsuchihashi, Osamu Uchikoga, Maki Koyanagi, Hisashi Yoshimura, Shiro Tachibana, et al.

    A 60-year-old man complaining of black stool, body weight loss, and anemia, was examined and diagnosed with advanced gastric cancer (M, type 3, por 2, cT3, cN3, cH0, cP0, cM0, cStage IV). A poor prognosis was predicted, yet we tried neoadjuvant chemotherapy (NAC) expecting downstaging of the tumor. Considering the efficacy and safety, we chose S-1+CDDP as the NAC regimen. S-1 (120 mg/day) was administered orally for 21 days, followed by CDDP (75 mg/body) div on day 8. Distal partial gastrectomy and lymph node dissection (D2) were performed, with Billroth I reconstruction. Histological examination of the resected stomach and lymph nodes revealed no residual cancer cells, suggesting complete histological remission (grade 3) according to the Japanese classification of gastric carcinoma.


    • 1 October 2006
      • Vol. 103  (10) , 1127-33

    [A case of localized AL-type amyloidosis of the stomach].

    by Takashi Fujisawa, Osamu Uchikoga, Yasumichi Seki, Keisuke Kitaura, Toshiyuki Mori, Wataru Sano, Sachiko Ouchi, Hirotsugu Hirano

    A 78-year-old woman was admitted to our hospital for treatment of liver cirrhosis and an esophageal varix. Endoscopy revealed a protruding nodular lesion with a transparent smooth surface proximal to the pylorus, which was accompanied by a partly yellow-whitish spot. A depressed lesion with an even edge was found. Histologically, the protruding lesion and depressed lesion showed amyloid deposits, mainly in the mucosal layer. The lesions were found to correspond to AL type amyloidosis by immunochemical analysis. General examination showed no other amyloid deposits. Thus, we diagnosed localized amyloidosis of the stomach.

  • Nodule‐aggregating lesion of the ileum: Report of a case and a review of the literature

    by Norikazu Sakamoto, Takashi Fujisawa, Mitsuo Maeda, Kazuhiko Sakaguchi, Yutaka Onishi, Shoji Kuroda, Masanori Toyoda, Tetsuya Teranishi, Katsufumi Miyamoto, Nobuaki Kawaraya, et al.